Search Within

Joachim Yahalom

  1. "Jane Myers"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Radiation Oncology, Department of (8)
  6. Survivorship Research (8)

More Groups

People
  1. David Straus (8)
  2. Jane Myers (8)
  3. Bayard Clarkson (4)
  4. Andrew Zelenetz (3)
  5. Carol Portlock (3)
  6. Craig Moskowitz (3)

More People

Years
  1. 2004 (2)
  2. 2001 (1)
  3. 1998 (1)
  4. 1993 (1)
  5. 1992 (1)
  6. 1991 (1)

More Years

Publications
  1. Blood (3)
  2. Cancer (2)
  3. Journal of Clinical Oncology (2)
  4. Annals of Oncology (1)
Publishers
  1. American Society of Hematology (3)
  2. American Society of Clinical Oncology (2)
  3. Wiley Blackwell (2)
  4. Oxford University Press (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
    Journal Article

    Portlock, C. S.; Qin, J.; Schaindlin, P.; Roistacher, N.; Myers, J.; Filippa, D.; Louie, D.; Zelenetz, A. D.; O'Brien, J. P.; Moskowitz, C.; more...
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    Journal Article

    Straus, D. J.; Portlock, C. S.; Qin, J.; Myers, J.; Zelenetz, A. D.; Moskowitz, C.; Noy, A.; Goy, A.; Yahalom, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Serial gallium scans in patients with bulky early stage Hodgkin's disease treated with chemotherapy and irradiation predict outcome
    Meeting Abstract

    Rini, J.; Yeung, H.; Macapinlac, H.; Myers, J.; Larson, S.; Yahalom, J.; Glassman, J.; Straus, D.
    Blood (1998)

    Fulltext@MSK | Save
  • Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma: Results of a prospective randomized study
    Journal Article

    Yahalom, J.; Varsos, G.; Fuks, Z.; Myers, J.; Clarkson, B. D.; Straus, D. J.
    Cancer (1993)

    Fulltext@MSK | Save
  • Four cycles of chemotherapy and regional radiation therapy for clinical early‐stage and intermediate‐stage Hodgkin's disease
    Journal Article

    Straus, D. J.; Yahalom, J.; Gaynor, J.; Myers, J.; Koziner, B.; Caravelli, J.; Lee, B. J. 3rd; Nisce, L. Z.; McCormick, B.; Bajorunas, D.; more...
    Cancer (1992)

    Fulltext@MSK | Save
  • Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations
    Journal Article

    Yahalom, J.; Ryu, J.; Straus, D. J.; Gaynor, J. J.; Myers, J.; Caravelli, J.; Clarkson, B. D.; Fuks, Z.
    Journal of Clinical Oncology (1991)

    Fulltext@MSK | Save
  • Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy
    Journal Article

    Straus, D. J.; Gaynor, J. J.; Myers, J.; Merke, D. P.; Caravelli, J.; Chapman, D.; Yahalom, J.; Clarkson, B. D.
    Journal of Clinical Oncology (1990)

    Fulltext@MSK | Save